相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
J. -C. Soria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dose-escalated radiation therapy is associated with better overall survival in patients with bone metastases from solid tumors: a propensity score-matched study
Yung-Chih Chou et al.
CANCER MEDICINE (2017)
Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor-mutated lung cancer receiving tyrosine kinase inhibitors as first-line treatment
Tso-Fu Wang et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)
Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients
Akira Inoue et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs
Jessica J. Lin et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer
Qunying Lin et al.
CANCER EPIDEMIOLOGY (2015)
The IASLC Lung Cancer Staging Project Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer
Wilfried E. E. Eberhardt et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
A Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non-Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001
Eiki Ichihara et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registry
Florian Kocher et al.
LUNG CANCER (2015)
Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib
Kuan-Li Wu et al.
LUNG CANCER (2015)
Mechanisms of resistance to EGFR tyrosine kinase inhibitors
Lihua Huang et al.
ACTA PHARMACEUTICA SINICA B (2015)
Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis
Daichi Fujimoto et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study
Takashi Seto et al.
LANCET ONCOLOGY (2014)
Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)
S. Dearden et al.
ANNALS OF ONCOLOGY (2013)
Survival of lung adenocarcinoma patients with malignant pleural effusion
Shang-Gin Wu et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Yosuke Togashi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid Subgroup Analysis from a Randomized Phase 3 Study
Giorgio Vittorio Scagliotti et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing influence of exon 19 deletion on radiographic features
Akimasa Sekine et al.
LUNG CANCER (2012)
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS)
Masahiro Fukuoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database
Ramaswamy Govindan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
H Shigematsu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Vascular enclothelial growth factor in pleural effusions of different origin
U Sack et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways
R Sordella et al.
SCIENCE (2004)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
Angiogenesis in health and disease
P Carmeliet
NATURE MEDICINE (2003)
分享论文
